APOC3 and metabolic dysfunction-associated steatotic liver disease: Not long ago, ApoC3 polymorphisms were associated with the lean male population’s susceptibility to NAFLD and insulin resistance leading to a rise in ApoC3 plasma levels by approximately 30% and postprandial hypertriglyceridemia caused by ApoC3’s altering effect on lipoprotein lipase activity.